Ignite Creation Date:
2025-12-26 @ 5:20 PM
Ignite Modification Date:
2026-02-03 @ 9:51 AM
Study NCT ID:
NCT00598806
Status:
COMPLETED
Last Update Posted:
2017-11-13
First Post:
2008-01-11
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Single Dose Intravesical Apaziquone Postoperative in Patients Undergoing TURBT for Noninvasive Bladder Cancer (SPI-612)
Sponsor:
Spectrum Pharmaceuticals, Inc
Organization: